ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 225 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $4,122,000 | +251.4% | 77,106 | +218.6% | 0.33% | +178.3% |
Q2 2020 | $1,173,000 | -86.7% | 24,201 | -90.1% | 0.12% | -74.6% |
Q3 2019 | $8,825,000 | +771.2% | 245,234 | +546.8% | 0.47% | +1110.3% |
Q2 2019 | $1,013,000 | +46.8% | 37,915 | +47.5% | 0.04% | -2.5% |
Q1 2019 | $690,000 | -65.9% | 25,700 | -73.6% | 0.04% | -43.7% |
Q3 2018 | $2,024,000 | +41.9% | 97,500 | +134.9% | 0.07% | +222.7% |
Q1 2017 | $1,426,000 | -51.8% | 41,500 | -54.5% | 0.02% | -84.1% |
Q2 2016 | $2,960,000 | +1025.5% | 91,200 | +1347.6% | 0.14% | +245.0% |
Q2 2015 | $263,000 | -8.7% | 6,300 | -30.8% | 0.04% | -9.1% |
Q4 2014 | $288,000 | -24.4% | 9,100 | -40.9% | 0.04% | -39.7% |
Q3 2014 | $381,000 | -35.1% | 15,400 | -34.5% | 0.07% | +28.1% |
Q4 2013 | $587,000 | – | 23,500 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |